Next generation of tumor-activating type I IFN enhances anti-tumor immune responses to overcome therapy resistance
暂无分享,去创建一个
yang-xin fu | Jiankun Zhu | Yong Liang | Huiyu Li | Eric J Hsu | Xuezhi Cao | Jiaming Yang | Zhenxiang Hu | Jin Zhou
暂无分享,去创建一个
yang-xin fu | Jiankun Zhu | Yong Liang | Huiyu Li | Eric J Hsu | Xuezhi Cao | Jiaming Yang | Zhenxiang Hu | Jin Zhou